dc.creatorStites, Edward C.
dc.creatorWilen, Craig B.
dc.date.accessioned2020-08-26T15:16:34Z
dc.date.accessioned2022-09-23T18:46:06Z
dc.date.available2020-08-26T15:16:34Z
dc.date.available2022-09-23T18:46:06Z
dc.date.created2020-08-26T15:16:34Z
dc.identifier2666-6340
dc.identifierhttps://doi.org/10.1016/j.medj.2020.08.001
dc.identifierhttp://hdl.handle.net/20.500.12010/12306
dc.identifierhttps://doi.org/10.1016/j.medj.2020.08.001
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3507037
dc.description.abstractTesting for SARS-CoV-2 has attracted a tremendous amount of attention as a tool to manage the ongoing COVID-19 pandemic. Although diagnostic laboratory testing is utilized ubiquitously by physicians and encountered regularly by individuals receiving medical care, several aspects of test interpretation are incompletely understood by medical communities and the general population, creating a significant challenge in minimizing the damage caused by disease spread through informed decision making and proper testing utilization. Here, general principles of test interpretation are reviewed and applied to specific examples, such as whether asymptomatic individuals should be tested, what it means to test positive (or negative), and how to interpret tests for “immunity passports”. Unexpectedly, the answers seem to run contrary to many of the popular narratives about testing as a tool for managing COVID-19. Although testing is an important and essential part of managing diseases like COVID-19, improper utilization can potentially have unintended negative consequences.
dc.languageeng
dc.publisherMed
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.rightsAcceso restringido
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectSARS-CoV-2
dc.subjectCOVID-19
dc.subjectPandemic
dc.subjectDiagnostic tests
dc.titleThe Interpretation of SARS-CoV-2 diagnostic tests


Este ítem pertenece a la siguiente institución